Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes
Status:
Terminated
Trial end date:
2008-03-10
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia, Europe and Oceania. The aim of this research study is to
compare the efficacy of adding inhaled preprandial insulin to glimepiride compared to adding
rosiglitazone to glimepiride for the treatment of type 2 diabetes and to verify its safety
(hypoglycaemia, pulmonary function, body weight, insulin antibodies and side effects)